NO20025132L - Natrium-hydrogen-byttertype 1-inhibitor (NHE-1) - Google Patents

Natrium-hydrogen-byttertype 1-inhibitor (NHE-1)

Info

Publication number
NO20025132L
NO20025132L NO20025132A NO20025132A NO20025132L NO 20025132 L NO20025132 L NO 20025132L NO 20025132 A NO20025132 A NO 20025132A NO 20025132 A NO20025132 A NO 20025132A NO 20025132 L NO20025132 L NO 20025132L
Authority
NO
Norway
Prior art keywords
nhe
inhibitor
sodium
exchanger type
hydrogen exchanger
Prior art date
Application number
NO20025132A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025132D0 (no
Inventor
Weichao George Chen
Eric David Cox
Angel Guzman-Perez
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20025132D0 publication Critical patent/NO20025132D0/no
Publication of NO20025132L publication Critical patent/NO20025132L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20025132A 2000-04-28 2002-10-25 Natrium-hydrogen-byttertype 1-inhibitor (NHE-1) NO20025132L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28
PCT/IB2001/000277 WO2001083470A1 (fr) 2000-04-28 2001-02-28 Inhibiteurs de l'echangeur sodium-hydrogene de type 1

Publications (2)

Publication Number Publication Date
NO20025132D0 NO20025132D0 (no) 2002-10-25
NO20025132L true NO20025132L (no) 2002-12-12

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025132A NO20025132L (no) 2000-04-28 2002-10-25 Natrium-hydrogen-byttertype 1-inhibitor (NHE-1)

Country Status (40)

Country Link
EP (1) EP1276737A1 (fr)
JP (1) JP2003531900A (fr)
KR (1) KR20020093079A (fr)
CN (1) CN1225466C (fr)
AP (1) AP2002002651A0 (fr)
AR (1) AR028375A1 (fr)
AU (1) AU2001235896A1 (fr)
BG (1) BG107139A (fr)
BR (1) BR0110268A (fr)
CA (1) CA2407535A1 (fr)
CO (1) CO5221125A1 (fr)
CR (1) CR6797A (fr)
CZ (1) CZ20023408A3 (fr)
DZ (1) DZ3310A1 (fr)
EA (1) EA004882B1 (fr)
EE (1) EE200200615A (fr)
GT (1) GT200100064A (fr)
HN (1) HN2001000042A (fr)
HR (1) HRP20020851A2 (fr)
HU (1) HUP0300651A2 (fr)
IL (1) IL152075A0 (fr)
IS (2) IS6567A (fr)
MA (1) MA26897A1 (fr)
MX (1) MXPA02010600A (fr)
MY (1) MY133842A (fr)
NO (1) NO20025132L (fr)
NZ (1) NZ521348A (fr)
OA (1) OA12256A (fr)
PA (1) PA8513301A1 (fr)
PE (1) PE20011270A1 (fr)
PL (1) PL357765A1 (fr)
SK (1) SK14872002A3 (fr)
SV (1) SV2002000418A (fr)
TN (1) TNSN01065A1 (fr)
TR (1) TR200202439T2 (fr)
UA (1) UA73348C2 (fr)
UY (1) UY26680A1 (fr)
WO (1) WO2001083470A1 (fr)
YU (1) YU79602A (fr)
ZA (1) ZA200208605B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004518686A (ja) * 2001-01-31 2004-06-24 ファイザー・プロダクツ・インク ナトリウム−水素交換輸送体1型阻害剤のエタノラート
EP1456181A1 (fr) * 2001-12-19 2004-09-15 Pfizer Products Inc. Methodes de preparation d'inhibiteurs de type 1 d'echangeurs de sodium-hydrogene
MXPA04008646A (es) * 2002-05-02 2004-12-06 Pfizer Prod Inc Tratamiento para la diabetes y complicaciones diabeticas con inhibidores del nhe-1.
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
MXPA05008612A (es) * 2003-02-14 2005-12-05 Smithkline Beecham Corp Compuestos novedosos.
RU2518741C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU739403B2 (en) * 1998-02-27 2001-10-11 Pfizer Products Inc. N-((substituted five-membered di- or triaza diunsaturated ring)carbonyl) guanidine derivatives for the treatment of ischemia

Also Published As

Publication number Publication date
EE200200615A (et) 2004-04-15
WO2001083470A1 (fr) 2001-11-08
UA73348C2 (en) 2005-07-15
HN2001000042A (es) 2001-07-09
HUP0300651A2 (hu) 2003-07-28
HRP20020851A2 (en) 2005-02-28
JP2003531900A (ja) 2003-10-28
IL152075A0 (en) 2003-05-29
UY26680A1 (es) 2001-12-28
TR200202439T2 (tr) 2003-02-21
SV2002000418A (es) 2002-07-03
SK14872002A3 (sk) 2004-03-02
AR028375A1 (es) 2003-05-07
CN1225466C (zh) 2005-11-02
OA12256A (en) 2003-11-06
CA2407535A1 (fr) 2001-11-08
MA26897A1 (fr) 2004-12-20
PA8513301A1 (es) 2003-09-05
EA200201023A1 (ru) 2003-02-27
CO5221125A1 (es) 2002-11-28
PE20011270A1 (es) 2001-12-12
GT200100064A (es) 2002-03-22
CR6797A (es) 2004-05-17
BG107139A (bg) 2003-07-31
NO20025132D0 (no) 2002-10-25
AU2001235896A1 (en) 2001-11-12
IS6567A (is) 2002-09-24
EP1276737A1 (fr) 2003-01-22
EA004882B1 (ru) 2004-08-26
PL357765A1 (en) 2004-07-26
KR20020093079A (ko) 2002-12-12
ZA200208605B (en) 2003-10-24
MXPA02010600A (es) 2003-03-10
YU79602A (en) 2006-05-25
DZ3310A1 (fr) 2001-11-07
IS6588A (is) 2002-10-21
AP2002002651A0 (en) 2002-12-31
CZ20023408A3 (cs) 2004-01-14
NZ521348A (en) 2004-09-24
BR0110268A (pt) 2003-12-30
TNSN01065A1 (fr) 2005-11-10
MY133842A (en) 2007-11-30
CN1426404A (zh) 2003-06-25

Similar Documents

Publication Publication Date Title
DE60101714D1 (de) Wärmetauscher
DE50100984D1 (de) Plattenwärmetauscher
DE60012822D1 (de) Wärmetauscher
DE60109107D1 (de) Plattenwärmetauscher
DE60138964D1 (de) Wärmetauscher
DE69924306D1 (de) Wärmetauscher
DE60138767D1 (de) Wärmetauscher
DE60116596D1 (de) Wärmetauscher
DE10083636T1 (de) Wärmetauscher
DE60115565D1 (de) Wärmetauscher
DE60023394D1 (de) Wärmetauscher
DE60027489D1 (de) Wärmetauscher
ITMI20002039A0 (it) Scambiatore di calore
NO20025132D0 (no) Natrium-hydrogen-byttertype 1-inhibitor (NHE-1)
FI20002454A0 (fi) Lämmönsiirrin
DE69824454D1 (de) Wärmetauscher
DE60006813D1 (de) Wärmetauscher
ITMI20001583A0 (it) Scambiatore di calore
DE59905017D1 (de) Wärmeübertrager
NO20021821D0 (no) Natrium-hydrogen utvekslingstype 1 inhibitor krystaller
DE60102847D1 (de) Wärmetauscher
FI20002648A (fi) Lämmönsiirrin
FI981909A (fi) Lämmönsiirrin
ATA200698A (de) Wärmetauscher
SE0000586D0 (sv) Heat exchanger

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application